WEKO3
アイテム
{"_buckets": {"deposit": "c00d9fbb-9819-4c48-83ba-cc595504588c"}, "_deposit": {"created_by": 11, "id": "3835", "owners": [11], "pid": {"revision_id": 0, "type": "depid", "value": "3835"}, "status": "published"}, "_oai": {"id": "oai:shiga-med.repo.nii.ac.jp:00003835", "sets": ["216", "281"]}, "author_link": ["8455", "8454", "564", "8351", "8458", "8456", "8457"], "item_4_biblio_info_6": {"attribute_name": "書誌情報", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2021-03", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "2", "bibliographicPageEnd": "233", "bibliographicPageStart": "226", "bibliographicVolumeNumber": "64", "bibliographic_titles": [{}, {"bibliographic_title": "Obstetrics and Gynecology Science", "bibliographic_titleLang": "en"}]}]}, "item_4_creator_3": {"attribute_name": "著者別名", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "米岡, 完"}], "nameIdentifiers": [{"nameIdentifier": "8351", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "0000-0002-8255-6293", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0002-8255-6293"}]}, {"creatorNames": [{"creatorName": "村上, 節"}], "nameIdentifiers": [{"nameIdentifier": "564", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "20240666", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=20240666"}, {"nameIdentifier": "0000-0002-0250-0856", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0002-0250-0856"}]}]}, "item_4_description_14": {"attribute_name": "フォーマット", "attribute_value_mlt": [{"subitem_description": "pdf", "subitem_description_type": "Other"}]}, "item_4_description_4": {"attribute_name": "抄録", "attribute_value_mlt": [{"subitem_description": "Objective:\nThis study aimed to investigate the prognosis of patients with intermediate-risk cervical cancer and to evaluate the necessity of adjuvant therapy. ", "subitem_description_type": "Abstract"}, {"subitem_description": "Methods:\nWe conducted a retrospective chart review of patients with stage IB-II cervical cancer who underwent type III radical hysterectomy with pelvic lymphadenectomy between 2008 and 2017. In our institution, radical hysterectomy is performed as an open surgery and not as a minimally invasive surgery, and adjuvant therapy is not administered to patients with intermediate-risk cervical cancer. The intermediate-risk group included patients with 2 or more of the following factors: tumor size \u003e4 cm, stromal invasion \u003e1/2, and lymphovascular stromal invasion. Intermediaterisk patients with squamous cell carcinoma were included in the I-SCC group, whereas those with endocervical adenocarcinoma, usual type, or adenosquamous carcinoma were included in the I-Adeno group. ", "subitem_description_type": "Abstract"}, {"subitem_description": "Results:\nThere were 34 and 18 patients in the I-SCC and I-Adeno groups, respectively. The 5-year recurrence-free survival (RFS) and overall survival rates in the I-SCC group were 90.5% (95% confidence interval [CI], 85.3-95.7%) and 100% (95% CI, 100%), respectively, whereas those in the I-Adeno group were 54.9% (95% CI, 42.0-67.9%) and 76.1% (95% CI, 63.7-88.4%), respectively. Multivariate analysis revealed that endocervical adenocarcinoma, usual type, or adenosquamous carcinoma, and tumor size \u003e4 cm had worse RFS. ", "subitem_description_type": "Abstract"}, {"subitem_description": "Conclusion:\nThe I-SCC group had good prognosis without adjuvant therapy; therefore, adjuvant therapy may be omitted in these patients. In contrast, the I-Adeno group had poor prognosis without adjuvant therapy; therefore, adjuvant therapy should be considered in their treatment. ", "subitem_description_type": "Abstract"}]}, "item_4_description_42": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"subitem_description": "Journal Article", "subitem_description_type": "Other"}]}, "item_4_publisher_32": {"attribute_name": "出版者", "attribute_value_mlt": [{"subitem_publisher": "Korean Society of Obstetrics and Gynecology"}]}, "item_4_relation_10": {"attribute_name": "PubMed番号", "attribute_value_mlt": [{"subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "33752280", "subitem_relation_type_select": "PMID"}}]}, "item_4_relation_11": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.5468/ogs.20243"}], "subitem_relation_type": "isIdenticalTo", "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.5468/ogs.20243", "subitem_relation_type_select": "DOI"}}]}, "item_4_relation_13": {"attribute_name": "PMCID", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "PMC7991004"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7991004/", "subitem_relation_type_select": "URI"}}]}, "item_4_rights_12": {"attribute_name": "権利", "attribute_value_mlt": [{"subitem_rights": "© 2021 Korean Society of Obstetrics and Gynecology"}]}, "item_4_source_id_7": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "22878572", "subitem_source_identifier_type": "ISSN"}]}, "item_4_version_type_15": {"attribute_name": "著者版フラグ", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_creator": {"attribute_name": "著者", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "YONEOKA, Yutaka"}], "nameIdentifiers": [{"nameIdentifier": "8351", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "0000-0002-8255-6293", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0002-8255-6293"}]}, {"creatorNames": [{"creatorName": "KOBAYASHI-KATO, Mayumi"}], "nameIdentifiers": [{"nameIdentifier": "8454", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "TANASE, Yasuhito"}], "nameIdentifiers": [{"nameIdentifier": "8455", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "UNO, Masaya"}], "nameIdentifiers": [{"nameIdentifier": "8456", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "ISHIKAWA, Mitsuya"}], "nameIdentifiers": [{"nameIdentifier": "8457", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "MURAKAMI, Takashi"}], "nameIdentifiers": [{"nameIdentifier": "564", "nameIdentifierScheme": "WEKO"}, {"nameIdentifier": "20240666", "nameIdentifierScheme": "e-Rad", "nameIdentifierURI": "https://kaken.nii.ac.jp/ja/search/?qm=20240666"}, {"nameIdentifier": "0000-0002-0250-0856", "nameIdentifierScheme": "ORCID", "nameIdentifierURI": "https://orcid.org/0000-0002-0250-0856"}]}, {"creatorNames": [{"creatorName": "KATO, Tomoyasu"}], "nameIdentifiers": [{"nameIdentifier": "8458", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "ファイル情報", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2021-04-12"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "ogs.20243.pdf", "filesize": [{"value": "190.5 kB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensefree": "Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.", "licensetype": "license_free", "mimetype": "application/pdf", "size": 190500.0, "url": {"label": "ogs.20243", "url": "https://shiga-med.repo.nii.ac.jp/record/3835/files/ogs.20243.pdf"}, "version_id": "59c212d1-be17-49bf-a1ac-da61d1181ece"}]}, "item_keyword": {"attribute_name": "キーワード", "attribute_value_mlt": [{"subitem_subject": "Adenocarcinoma", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Carcinoma", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Recurrence", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Squamous cells", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}, {"subitem_subject": "Uterine cervical neoplasms", "subitem_subject_language": "en", "subitem_subject_scheme": "Other"}]}, "item_language": {"attribute_name": "言語", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "資源タイプ", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "The baseline recurrence risk of patients with intermediate-risk cervical cancer.", "item_titles": {"attribute_name": "タイトル", "attribute_value_mlt": [{"subitem_title": "The baseline recurrence risk of patients with intermediate-risk cervical cancer."}]}, "item_type_id": "4", "owner": "11", "path": ["216", "281"], "permalink_uri": "http://hdl.handle.net/10422/00012945", "pubdate": {"attribute_name": "公開日", "attribute_value": "2021-04-12"}, "publish_date": "2021-04-12", "publish_status": "0", "recid": "3835", "relation": {}, "relation_version_is_last": true, "title": ["The baseline recurrence risk of patients with intermediate-risk cervical cancer."], "weko_shared_id": -1}
The baseline recurrence risk of patients with intermediate-risk cervical cancer.
http://hdl.handle.net/10422/00012945
http://hdl.handle.net/10422/000129455d615ce8-fa1a-42c6-8d3e-3670c14b3a4e
名前 / ファイル | ライセンス | アクション |
---|---|---|
ogs.20243 (190.5 kB)
|
Articles published in Obstet Gynecol Sci are open-access, distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
|
Item type | 学術雑誌論文 / Journal Article(1) | |||||
---|---|---|---|---|---|---|
公開日 | 2021-04-12 | |||||
タイトル | ||||||
タイトル | The baseline recurrence risk of patients with intermediate-risk cervical cancer. | |||||
言語 | ||||||
言語 | eng | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Adenocarcinoma | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Carcinoma | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Recurrence | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Squamous cells | |||||
キーワード | ||||||
言語 | en | |||||
主題Scheme | Other | |||||
主題 | Uterine cervical neoplasms | |||||
資源タイプ | ||||||
資源タイプ識別子 | http://purl.org/coar/resource_type/c_6501 | |||||
資源タイプ | journal article | |||||
著者 |
YONEOKA, Yutaka
× YONEOKA, Yutaka× KOBAYASHI-KATO, Mayumi× TANASE, Yasuhito× UNO, Masaya× ISHIKAWA, Mitsuya× MURAKAMI, Takashi× KATO, Tomoyasu |
|||||
著者別名 |
米岡, 完
× 米岡, 完× 村上, 節 |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Objective: This study aimed to investigate the prognosis of patients with intermediate-risk cervical cancer and to evaluate the necessity of adjuvant therapy. |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Methods: We conducted a retrospective chart review of patients with stage IB-II cervical cancer who underwent type III radical hysterectomy with pelvic lymphadenectomy between 2008 and 2017. In our institution, radical hysterectomy is performed as an open surgery and not as a minimally invasive surgery, and adjuvant therapy is not administered to patients with intermediate-risk cervical cancer. The intermediate-risk group included patients with 2 or more of the following factors: tumor size >4 cm, stromal invasion >1/2, and lymphovascular stromal invasion. Intermediaterisk patients with squamous cell carcinoma were included in the I-SCC group, whereas those with endocervical adenocarcinoma, usual type, or adenosquamous carcinoma were included in the I-Adeno group. |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Results: There were 34 and 18 patients in the I-SCC and I-Adeno groups, respectively. The 5-year recurrence-free survival (RFS) and overall survival rates in the I-SCC group were 90.5% (95% confidence interval [CI], 85.3-95.7%) and 100% (95% CI, 100%), respectively, whereas those in the I-Adeno group were 54.9% (95% CI, 42.0-67.9%) and 76.1% (95% CI, 63.7-88.4%), respectively. Multivariate analysis revealed that endocervical adenocarcinoma, usual type, or adenosquamous carcinoma, and tumor size >4 cm had worse RFS. |
|||||
抄録 | ||||||
内容記述タイプ | Abstract | |||||
内容記述 | Conclusion: The I-SCC group had good prognosis without adjuvant therapy; therefore, adjuvant therapy may be omitted in these patients. In contrast, the I-Adeno group had poor prognosis without adjuvant therapy; therefore, adjuvant therapy should be considered in their treatment. |
|||||
書誌情報 |
en : Obstetrics and Gynecology Science 巻 64, 号 2, p. 226-233, 発行日 2021-03 |
|||||
出版者 | ||||||
出版者 | Korean Society of Obstetrics and Gynecology | |||||
ISSN | ||||||
収録物識別子タイプ | ISSN | |||||
収録物識別子 | 22878572 | |||||
PMID | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | PMID | |||||
関連識別子 | 33752280 | |||||
PMCID | ||||||
識別子タイプ | URI | |||||
関連識別子 | http://www.ncbi.nlm.nih.gov/pmc/articles/pmc7991004/ | |||||
関連名称 | PMC7991004 | |||||
DOI | ||||||
関連タイプ | isIdenticalTo | |||||
識別子タイプ | DOI | |||||
関連識別子 | https://doi.org/10.5468/ogs.20243 | |||||
関連名称 | 10.5468/ogs.20243 | |||||
権利 | ||||||
権利情報 | © 2021 Korean Society of Obstetrics and Gynecology | |||||
フォーマット | ||||||
内容記述タイプ | Other | |||||
内容記述 | ||||||
著者版フラグ | ||||||
出版タイプ | VoR | |||||
出版タイプResource | http://purl.org/coar/version/c_970fb48d4fbd8a85 | |||||
資源タイプ | ||||||
内容記述タイプ | Other | |||||
内容記述 | Journal Article |